Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
eHealth Earns HITRUST i1 Certification to Enhance Data Security
eHealth, a top company that provides healthcare technology solutions, has successfully earned the HITRUST i1 certification. This shows how serious eHealth is about keeping sensitive data safe and lowering the risk of cybersecurity issues. This success shows how committed eHealth is to protecting patient information and following industry rules. The HITRUST i1 certification is a tough standard that helps companies handle information security risks well, and eHealth reaching this goal shows the company is taking a strong, proactive stance on data protection in a complicated cyber world.
Sleep Apnea Threatens Women’s Cognitive Health
The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research shows a troubling connection between the severity of obstructive sleep apnea (OSA) during REM sleep and increased risk of verbal memory decline in older adults—an early indicator of Alzheimer’s disease. This is where key specialists like Vivos Therapeutics step in, offering focused treatments to fight OSA and its other ramifications.
Binaytara Launches OncoBlast: CME Oncology Game App
Binaytara announces the launch of the full version of OncoBlast, the world’s first game-based application that provides free CME-accredited, oncology-centered courses to healthcare professionals. OncoBlast combines expert oncology education with an engaging gaming experience, providing an innovative way for oncology practitioners to stay up-to-date on the constantly evolving landscape of the latest cancer treatment breakthroughs.
Leniobio Gets €3.7M EU4Health Grant for ALiCE Development
LenioBio GmbH has been awarded EU4Health funding by the European Health and Digital Executive Agency (HaDEA), which implemented the corresponding call for proposals on behalf of the European Commission’s Health Emergency Preparedness and Response Authority (HERA). The project will focus on further development of the cell-free protein expression system, ALiCE, as an innovative, rapid and on-demand medicine manufacturing technology with strategic value for Europe, fitting into the mission of HERA. The project has been awarded a grant of EUR 3.7M and commenced on 1st July 2025, continuing until late 2027.
CareBand Wins U.S. Patent for Tri-Radio Tracking Wearable
CareBand, announced the award of U.S. Patent 12,298,410, “Wireless Devices, Systems and Methods for Long–Range Radio–Frequency Location Tracking of Objects.” The patent protects core logic that lets a single wearable roam automatically among Bluetooth Low Energy (BLE), nationwide low–power wide–area networks (LPWAN), and direct–to–satellite links, all while using very little battery power. With this latest grant, CareBand’s portfolio grows to 16 issued patents that stretch back to 2014.
Precision BioSciences Earns FDA Orphan Drug Status for Duchenne Muscular Dystrophy
Precision BioSciences has been given Orphan Drug Designation by the U.S. Food and Drug Administration for its new treatment, PBGENE DMD, which is being developed to help people with Duchenne Muscular Dystrophy (DMD). This is a big step because it shows that the treatment has the potential to help with this rare and serious genetic disease that affects muscle function in children and young adults. The Orphan Drug status gives the company some special benefits during development and also allows them to have exclusive rights to the treatment for a certain time, which helps them keep working on getting it to patients who need it.
To share your insights, please write to us at sudipto@intentamplify.com
